Craig Stoltz's SharePosts

Proscar, Aggressive Tumor Risk Questioned

by Craig Stoltz on Prostate
Wednesday, May 21 2008

Proscar, a widely used drug used to shrink the prostate, may not cause aggressive prostate cancer tumors after all. Back in 2003, a big government study found that Proscar reduced risk of developing prostate cancer by 25 percent--but appeared to boost the incidence of aggressive, potentially lethal tumors. Well, five years later doctors... Read more Chevron

Be the first to comment |

Notify me when there are new comments

Waiting: Perhaps Less of a Stressor Than Expected

by Craig Stoltz on Prostate
Monday, October 01 2007

One of the most persuasive arguments against "watchful waiting"--taking no action on slow-growing prostate cancer contained to the gland until circumstances change--is that the anxiety of knowing there's a cancer down there is too much to bear. A surprising new study shows that, at least in one group of men observed, watchful waiters... Read more Chevron

Add comment | 1 Comments |

Notify me when there are new comments

Finasteride, Prostate Growth... and Cancer Risk

by Craig Stoltz on Prostate
Monday, September 17 2007

A fascinating study out of the National Cancer Institute has significant implications for men at risk for prostate cancer and men with enlarged prostates--for most men, really. But the study invites possible overinterpretation. Let's parse it carefully. Bottom line first Finasteride, a drug used to treat benign prostatic hyperplasia... Read more Chevron

Be the first to comment |

Notify me when there are new comments

Craig Stoltz's SharePosts

Proscar, Aggressive Tumor Risk Questioned

Waiting: Perhaps Less of a Stressor Than Expected

Finasteride, Prostate Growth... and Cancer Risk

Ask a Question